Charles N. Adelson, Ph.D.
Patent AgentAbout
Areas of FocusPatent Development and Strategy
EXPERIENCE
- Represented biologics startup in $177 million IPO
- Represented companies and investors in IP due diligences
- Represented pharmaceutical companies developing cancer, antibiotic, ocular, and cell-based therapeutics
- Represented medical diagnostics companies during diagnostic platform development
Education
- B.A., Chemistry, Grinnell College 2012
with honors - Ph.D., Stanford University 2019
Publications
- Co-author, et al. Characterization of the preprocessed copper site in amine oxidase and assignment of the reactive copper site in topaquinone biogenesis. Journal of the American Chemical Society, 2019, 141(22):8877-8890
- Co-author with Vermesh, O., Aalipour, A., Ge, T. J., Saenz, Y., Gui, Y., Alam, I. S., Park, S., et al. An intravascular magnetic wire for the high-throughput retrieval of circulating tumour cells in vivo. Nature Biomedical Engineering, 2018, 2, 696-705